Targeted Alpha Therapy
Maria BettiDirector
European Commission Joint Research Centre Directorate Nuclear Safety
and Security
Targeted Therapy
Selective killing tumor cells
Limited side effects (healthy tissue)
2017‐09‐21 4
High energyHigh ionisation density
Clinical Testings
Before treatmentDec. 2014
After 4 treatmentsSept. 2015
Complete response
Life expectation considerably
increased
2017‐09‐21 5
Secure supply of 225Ac (IAEA TCP) - Production
Case Study 1 – Argentina
Training
Know-How transfer
Hosting staff at JRC
2017‐09‐21 6
Case Study 2 – South AfricaKnowledge Transfer in the Hospitals
Education to use of radio isotopes
Building capacity to treat prostate cancer
Establishing Regional Training Centre in Africa
2017‐09‐21 7
2017‐09‐21 8
225Ac‐PSMA617: Pretoria experience
1 x225Ac‐PSMA
(10 MBq)
Case Study 2 – South Africa
April 2017PSA = 2280 ng/ml
July 2017 PSA = 205 ng/ml
Follow-up Clinical trials
Specific Regulations
Pharmaceutical Industry Involvement
Looking forward to the future2017‐09‐21 9